Kyphon Inc

Kyphon — Merger or Acquisition (July 2007)

13 slides from Kyphon's merger presentation, Jul 30, 2007

  1. Slide 1: Schedule 14A

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate b

  2. Slide 2: Filing Party and Date Filed

    (3) Filing Party: (4) Date Filed: The following slides were made available during the course of meetings with and presentations to certain investors beginning on July 30, 2007:

  3. Slide 3: Kyphon and Medtronic Proposed Acquisition

    Kyphon and Medtronic Proposed Acquisition July 30, 2007 1

  4. Slide 4: Forward-Looking Statements

    Forward-Looking Statements This investor overview contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward looking statements include, but are not limited to, those that use words such as “believes,” “anticipates,” “targets,” “inten

  5. Slide 5: Important Additional Information

    Important Additional Information Kyphon intends to file with the Securities and Exchange Commission (“SEC”) a proxy statement and other relevant documents in connection with the proposed acquisition. KYPHON’S STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHER RELEVANT DOCUMENTS WHEN THEY B

  6. Slide 6: Transaction Overview

    Transaction Overview Consideration $71.00 per share in cash Transaction Value $3.9 billion plus $320 million in payments associated with St. Francis Medical, Inc. acquisition and proposed acquisition of spine-related assets of Disc-O-Tech Medical Technologies, Ltd. 32% over closing price of Kyphon’s

  7. Slide 7: Selected precedent transactions

    Selected precedent transactions Spine/ortho transaction comps ($ millions) Date Transaction TV / LTM TV / FTM announced Target company Acquiror Business description value (TV) Sales Sales 07/27/2007 Kyphon¹ Medtronic Medical technology for spine $4,351 9.8x 7.0x 12/18/2006 Biomet Private equity inve

  8. Slide 8: Precedent premiums

    Precedent premiums Announceddeals with US target, 2004 —Q12007, % average premium to announcement Precedent premiums One-month premium¹ Selected transactions¹ Mean Median Premium paid Target name 1-day 30-day 38% 37% Kyphon 32.3% 45.4% Cytyc 32.6% 32.4% Biomet 4.8% 26.7% 30% 30% 29% Conor Medsystems

  9. Slide 9: Kyphon at a Glance

    Kyphon at a Glance Medical device company focused on minimally invasive spine market Pioneered balloon kyphoplasty - a novel procedure for repairing vertebral compression fractures Three product platforms serve estimated $6 billion potential market – Spinal Fracture Repair & Management (~$3 billion)

  10. Slide 10: Medtronic at a Glance

    Medtronic at a Glance Medtronic is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world Founded in 1949, the company’s FY07 revenues were $12.3 billion Seven sectors serve estimated $80 billion potential market – Car

  11. Slide 11: Creating a Global Leader in the Minimally Invasive Spine Market

    Creating a Global Leader in the Minimally Invasive Spine Market Allows more patients of all ages to receive benefits of modern, minimally invasive spinal treatments earlier in care Combines two world-class sales organizations to better serve our patients and clinicians Extends product offerings into

  12. Slide 12: Roadmap To Completion

    Roadmap To Completion Event Expected Timeline Execute definitive agreement Completed Kyphon shareholder vote 3-5 months Receive all regulatory clearances First calendar quarter of 2008 Close transaction Targeted in first calendar quarter of 2008 10

  13. Slide 13: Conclusion

    Conclusion Offers outstanding premium and immediate return on investment for shareholders Provides Kyphon with a stronger platform for growth Leverages combined organization’s world-class sales forces and expertise in developing and marketing innovative products Anticipated to close in first calenda

Kyphon — Merger or Acquisition (July 2007) on 6ix